Literature DB >> 19601387

Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities.

Lisa D DiMartino1, Lesley H Curtis, Roger L Williams, Darrell R Abernethy, Kevin A Schulman.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19601387

Source DB:  PubMed          Journal:  Food Drug Law J        ISSN： 1064-590X            Impact factor:   0.619


× No keyword cloud information.
  3 in total

1.  Identifying newly approved medications in Medicare claims data: a case study using tocilizumab.

Authors:  Jeffrey R Curtis; Fenglong Xie; Rui Chen; Lang Chen; Meredith L Kilgore; James D Lewis; Huifeng Yun; Jie Zhang; Nicole C Wright; Elizabeth Delzell
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-09-09       Impact factor: 2.890

2.  Attentional control and subjective executive function in treatment-naive adults with Attention Deficit Hyperactivity Disorder.

Authors:  Venke Arntsberg Grane; Tor Endestad; Arnfrid Farbu Pinto; Anne-Kristin Solbakk
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

3.  Pharmacovigilance Considerations for Biosimilars in the USA.

Authors:  Gustavo Grampp; Thomas Felix
Journal:  BioDrugs       Date:  2015-10       Impact factor: 5.807
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.